Stockreport

OS Therapies Provides Corporate Update

OS Therapies Incorporated  (OSTX) 
PDF Strong cash position relative to monthly burn and cash needs into mid-2026Significant regulatory milestones upcoming in OST-HER2 osteosarcoma programPending acquisition [Read more]